YARD-FORCE-UK
19.1.2023 06:23:36 CET | Business Wire | Press release
David Domoney highlights the ever-growing garden trend of manicuring. Keeping a neat and tidy garden is important, especially with the rise in popularity of outdoor entertaining. From trimming hedges and edges of lawns to cleaning your patio for a pristine garden, choosing the right tool for the job is crucial. With so much choice in the market, selecting powered garden tools to make the job of garden manicuring both easy, professional and all importantly, fun is a hot topic. In partnering with Yard Force®, David Domoney hopes to encourage people into their gardens and highlight the right time to do specific green preening tasks in the year. Utilising the tools at the right time of the year ensures you get the most out of them as well as making sure your garden is in the best shape.
David said, “By selecting the right tool for the job, it enables you to get the task at hand done most effectively and efficiently, so you have more time to spend enjoying a beautiful garden. In learning when is best to trim hedges, mow the lawn and general garden maintenance, we make time in the garden so much more enjoyable whilst protecting garden wildlife. It opens doors to learning new gardening techniques that will become part of regular gardening routines for a well-cared-for garden.”
Yard Force® is an internationally recognised brand with years of industry experience and knowledge.
David continues, “Giving people access to a better gardening experience is always a good thing; with practical advice on making the most of their garden and the tools necessary to give great results with little effort. The more we can do using professional electric-powered equipment at the right time of year, leaves us more time to enjoy the garden.
I want to make the tasks in the garden both rewarding and fun and using practical power tools that take the hard work out of garden maintenance. The range of cordless products and battery-share technology makes the range hassle-free, convenient, and a more sustainable option for beginners and keen gardeners alike. Within Yard Force’s 40V range, there is the Cordless Lawnmower, Hedge Trimmer, Grass Trimmer which are really innovative products that showcase game-changing technology.”
The partnership between David Domoney and Yard Force continues to encourage budding gardeners and virtuosos to get outside and give their gardens the best care. Through instructive videos, demos, gardening tips and fantastic giveaways, the knowledge and expertise will promote the range and how to get the most from the tools.
Notes to Editors:
David Domoney:
David Domoney is a seasoned gardening television broadcaster and currently presents on ITV’s ‘Love Your Garden’, ‘Love Your Weekend’ and is also the gardening presenter for ITV’s ‘This Morning’. He is a winner of 30 RHS Medals with two Best in Show category trophies and the Prince Edward Award for Horticulture Excellence. David is also known for pioneering campaigns Cultivation Street as well as Illumination Street, brightening up Britain’s streets at Christmas. David also writes a gardening column for Grow Your Own magazine.
Yard Force UK:
Yard Force are excited and proud to announce that we have partnered with seasoned gardening television presenter David Domoney to endorse our range of innovative, durable and high-performance garden power tools.
David is best known for presenting ITV’s most popular Gardening Show ‘Love your Garden’ and is also the resident gardening presenter for ITV’s flagship daytime show ‘This Morning’.
David's 40 years’ of experience in horticulture and dynamic enthusiastic character made him the perfect choice to collaborate with to help endorse our innovative and quality lead products.
Introducing a household name to represent our brand instils the confidence we have in our products and their performance. David says:
‘Like anything in the garden, once you know how, it becomes so easy. In learning how to look after our gardens properly, using power tools where needed, we make time in the garden so much more enjoyable and open doors to learning new gardening techniques and having access to a healthy and well-cared-for garden.”
We will be working closely with David throughout the year to produce top gardening tips for you to use around the garden, create some instructive videos designed to encourage you and your family to get back outside and exciting GIVEAWAYS featuring chosen products. To be in with the chance of winning and accessing these great promotions we have created a dedicated promotional code which will enable you to receive discounts and added extras all year round! All you need to do is:
SIGN UP TO RECEIVE THE PROMOTIONAL CODE below:
www.yardforce.eu/david
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230118005607/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
